FDA.reportPublic FDA data

{2 (baloxavir marboxil 20 MG Oral Tablet) } Pack

RxCUI
2100024
RxNorm name
{2 (baloxavir marboxil 20 MG Oral Tablet) } Pack
Display name
{2 (baloxavir marboxil 20 MG Oral Tablet) } Pack
Full name
{2 (baloxavir marboxil 20 MG Oral Tablet) } Pack
Term type
GPCK
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e9e6990a-66d3-4e13-b823-ff04d2d65886{2 (baloxavir marboxil 20 MG Oral Tablet) } Pack [GPCK] · baloxavir marboxil 40 MG Dose Pack (2 x 20 MG Tablets) [PSN] · baloxavir marboxil 40 MG Dose Pack (2 x 20 MG Tablets) [SY]35These highlights do not include all the information needed to use XOFLUZA safely and effectively. See full prescribing information for XOFLUZA. XOFLUZA ® (baloxavir marboxil) tablets, for oral use XOFLUZA ® (baloxavir marboxil) for oral suspension Initial U.S. Approval: 201820210416